<DOC>
	<DOC>NCT01181388</DOC>
	<brief_summary>Superselective IRA infusion of tirofiban may improve myocardial reperfusion and reduce bleeding complications in AMI patients.</brief_summary>
	<brief_title>Impacts of Superselective Infarct-related Artery (IRA) Infusion of Tirofiban on Myocardial Reperfusion and Bleeding Complications in Acute Myocardial Infarction (AMI) Patients</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<criteria>STEMI patients chest pain for less than 12hr plan to PCI LM lesion stent thrombosis cardiac shock thrombocytopenia allergy to asprin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>